Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127190431 | 12719043 | 1 | I | 20160821 | 20160905 | 20160906 | 20160906 | EXP | FR-ROCHE-1826360 | ROCHE | 49.00 | YR | F | Y | 0.00000 | 20160907 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127190431 | 12719043 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | Y | 103705 | 700 | MG | SOLUTION FOR INFUSION | QD | ||||||
127190431 | 12719043 | 2 | SS | IFOSFAMIDE EG | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | Y | 6F284H6 | 0 | 8 | G | QD | ||||||
127190431 | 12719043 | 3 | SS | ETOPOPHOS | ETOPOSIDE PHOSPHATE | 1 | Intravenous (not otherwise specified) | Y | 0 | 190 | MG | QD | |||||||
127190431 | 12719043 | 4 | SS | CARBOPLATINE | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | Y | 0 | 800 | MG | QD | |||||||
127190431 | 12719043 | 5 | SS | EMEND | APREPITANT | 1 | Oral | Y | 0 | 205 | MG | /cycle | |||||||
127190431 | 12719043 | 6 | SS | MESNA. | MESNA | 1 | Intravenous (not otherwise specified) | Y | 0 | ||||||||||
127190431 | 12719043 | 7 | C | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
127190431 | 12719043 | 8 | C | INNOHEP | TINZAPARIN SODIUM | 1 | 0 | ||||||||||||
127190431 | 12719043 | 9 | C | NEORECORMON | ERYTHROPOIETIN | 1 | 0 | ||||||||||||
127190431 | 12719043 | 10 | C | THYROZOL | METHIMAZOLE | 1 | 0 | ||||||||||||
127190431 | 12719043 | 11 | C | LUTENYL | NOMEGESTROL ACETATE | 1 | 0 | ||||||||||||
127190431 | 12719043 | 12 | C | IMOVANE | ZOPICLONE | 1 | 0 | ||||||||||||
127190431 | 12719043 | 13 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127190431 | 12719043 | 14 | C | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
127190431 | 12719043 | 15 | C | DUPHALAC (AUSTRALIA) | 2 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127190431 | 12719043 | 1 | Burkitt's lymphoma |
127190431 | 12719043 | 2 | Burkitt's lymphoma |
127190431 | 12719043 | 3 | Burkitt's lymphoma |
127190431 | 12719043 | 4 | Burkitt's lymphoma |
127190431 | 12719043 | 5 | Prophylaxis of nausea and vomiting |
127190431 | 12719043 | 6 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127190431 | 12719043 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127190431 | 12719043 | Headache | |
127190431 | 12719043 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127190431 | 12719043 | 1 | 20160819 | 20160819 | 0 | |
127190431 | 12719043 | 2 | 20160820 | 20160820 | 0 | |
127190431 | 12719043 | 3 | 20160819 | 20160821 | 0 | |
127190431 | 12719043 | 4 | 20160820 | 20160820 | 0 | |
127190431 | 12719043 | 5 | 20160820 | 20160821 | 0 | |
127190431 | 12719043 | 6 | 20160820 | 20160820 | 0 |